Laurence Jay Korn, Director at PDL BIOPHARMA, INC. (PDLI), sold 80,000 shares at $32.31 ($2.6M) on 2006-03-08, disclosed to the SEC on 2006-03-10.
Scheduled sale ($2.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.30 | 28,300 | $914K | 35.1% |
| 2 | $32.31 | 10,000 | $323K | 12.4% |
| 3 | $32.32 | 1,300 | $42K | 1.6% |
| 4 | $32.33 | 400 | $13K | 0.5% |
| 5 | $32.80 | 40,000 | $1.3M | 50.4% |
| Total | $32.55 avg | 80,000 |
| $2.6M |
| 100% |
| Filing → |
| PDLI | SELL | 2006-03-03 | $789K | — | Filing → |
| PDLI | SELL | 2006-03-02 | $6K | — | Filing → |
| PDLI | SELL | 2006-01-11 | $2.2M | — | Filing → |